Covered recipient · General Payments record
VERN C JUEL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2024
$41,005.13
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $22,830.00 | 6 |
| Travel and Lodging | $1,374.42 | 6 |
| Food and Beverage | $518.74 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $12,670.85 | 4 |
| Amgen Inc. | $10,850.34 | 13 |
| Janssen Scientific Affairs, LLC | $1,090.00 | 1 |
| ARGENX US, INC. | $111.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $5,900.00 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093999226 | CMS |
| Alexion Pharmaceuticals, Inc. | $1,770.00 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094007066 | CMS |
| Alexion Pharmaceuticals, Inc. | $280.85 | 10/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1094030110 | CMS |
| Alexion Pharmaceuticals, Inc. | $4,720.00 | 10/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093882907 | CMS |
| Amgen Inc. | $149.35 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115777668 | CMS |
| Amgen Inc. | $168.37 | 05/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115777677 | CMS |
| Amgen Inc. | $175.00 | 05/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115777686 | CMS |
| Amgen Inc. | $175.00 | 05/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115777694 | CMS |
| Amgen Inc. | $21.86 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115777702 | CMS |
| Amgen Inc. | $23.14 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115777709 | CMS |
| Amgen Inc. | $42.31 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115777719 | CMS |
| Amgen Inc. | $51.57 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115777728 | CMS |
| Amgen Inc. | $535.20 | 05/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115777738 | CMS |
| Amgen Inc. | $40.00 | 05/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115777745 | CMS |
| Amgen Inc. | $6,600.00 | 05/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115777752 | CMS |
| Amgen Inc. | $118.54 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115777769 | CMS |
| Amgen Inc. | $2,750.00 | 11/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115777761 | CMS |
| ARGENX US, INC. | $111.97 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142118213 | CMS |
| Janssen Scientific Affairs, LLC | $1,090.00 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1078854036 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.